Seres Therapeutics, Inc.·4

Sep 30, 4:30 PM ET

Young Teresa L. 4

4 · Seres Therapeutics, Inc. · Filed Sep 30, 2025

Insider Transaction Report

Form 4
Period: 2025-09-26
Young Teresa L.
See Remarks
Transactions
  • Award

    Restricted Stock Units

    2025-09-26+3,9983,998 total
    Common Stock (3,998 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
  • [F2]The RSUs will vest in a single installment on November 15, 2025, subject to the Reporting Person's satisfaction of the terms contemplated in the award agreement.The RSUs have no expiration date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4